Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease

Abstract

Patients with chronic kidney disease (CKD) exhibit reduced exercise capacity, poor physical function and symptoms of fatigue. The mechanisms that contribute to this are not clearly defined but may involve reductions in mitochondrial function, mass and biogenesis. Here we report on the effect of non-dialysis dependent CKD (NDD-CKD) on mitochondrial mass and basal expression of transcription factors involved in mitochondrial biogenesis compared to a healthy control cohort (HC). In addition, we sought to investigate the effect of a 12-week exercise-training programme on these aspects of mitochondrial dysfunction in a NDD-CKD cohort.For the comparison between NDD-CKD and HC populations, skeletal muscle biopsies were collected from the vastus lateralis (VL) of n=16 non-dialysis dependent CKD patient's stage 3b-5 (NDD-CKD) and n=16 healthy controls matched for age, gender and physical activity (HC). To investigate the effect of exercise training, VL biopsies were collected from n=17 NDD-CKD patients before and after a 12-week exercise intervention that was comprised of aerobic exercise (AE) or a combination of aerobic exercise and resistance training (CE). Mitochondrial mass was analysed by citrate synthase activity and mitochondrial protein content by Porin expression, whilst the expression of transcription factors involved in mitochondrial biogenesis were quantified by real-time qPCR. NDD-CKD patients exhibited a significant reduction in mitochondrial mass when compared to HC, coupled to a reduction in PGC-1α, NRF-1, Nrf2, TFam, mfn2 and SOD1/2 gene expression. 12-weeks of exercise training resulted in a significant increase in PGC-1α expression in both groups, with no further changes seen across indicators of mitochondrial biogenesis. No significant changes in mitochondrial mass were observed in response to either exercise programme. NDD-CKD patients exhibit reduced skeletal muscle mitochondrial mass and gene expression of 1756 |

Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease

“…Previous studies have reported that mice and human with CKD displayed lower mitochondrial content/density in skeletal muscle (14,20,47,58), which contrast the observations herein. There are several biomarkers used to estimate mitochondrial content in muscle, however they vary widely in accuracy when compared to electron microscopy (a gold standard) (59).…”

Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study

“…The underlying complex mechanisms of sarcopenia in the context of CKD are multifactorial. Whilst reductions in muscle strength are likely augmented by changes in muscle mass, the two are not exclusively related, and other detrimenta changes to muscle architecture, such as mitochondrial dysregulation 10,47 and motor neuron loss, may contribute 1 . In some individuals, sarcopenia is attributable to ageing (‘primary’ sarcopenia), 1 and unsurprisingly, we observed that older individuals were more likely to have probable sarcopenia, supporting previous research in CKD 12 .…”

Research Relationship Between Hemodialysis and Health-Related Quality of Life - A Cross-Sectional Study of Diagnosis and Duration of Hemodialysis

“…These common symptoms were considered to be expressed in the pain/discomfort dimension of the EQ-5D-5L. Although this study showed a decrease in the mobility dimension, many studies [22][23][24][25][26][27] showed a relationship between muscle weakness and exercise capacity in hemodialysis patients, and it was considered a QOL characteristic.…”